Skip to main content

LB Pharmaceuticals Inc

LBRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001691082

No open-market purchases or sales by LB Pharmaceuticals Inc insiders were filed in the last 90 days; 114 institutions reported holding it in 13F filings for Q2 2026, worth $965.9M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in LB Pharmaceuticals Inc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
114
+39 vs. Q1 2026
Shares held
29.8M
+1.61M (+5.7%) vs. Q1 2026
Total value
$965.9M
+$275.1M (+39.8%) vs. Q1 2026
New holders
42
41 more added
Sold out
3
13 more reduced

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 114 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 53 institutionsQ4 2025: 68 institutionsQ1 2026: 77 institutionsQ2 2026: 114 institutions
Value heldQ2 2026: $965.9M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $314.9MQ4 2025: $551.8MQ1 2026: $692.4MQ2 2026: $965.9M
Institutions holding LBRX and their total value by quarter
QuarterHoldersValue
Q2 2026114$965.9M
Q1 202677$692.4M
Q4 202568$551.8M
Q3 202553$314.9M
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding LB Pharmaceuticals Inc; share changes are against Q1 2026.

Institutions holding LBRX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
The PNC Financial Services Group, Inc.276$8.96K0.00%+131+90.3%Added
Sterling Capital Management LLC274$8.89K0.00%−94−25.5%Reduced
State of Wyoming198$6.43K0.00%+198New
GAMMA Investing LLC196$6.36K0.00%+34+21.0%Added
Global Retirement Partners, LLC189$6.13K0.00%+189New
Aster Capital Management (DIFC) Ltd65$2.11K0.00%+65New
Massmutual Trust Co FSB54$1.75K0.00%00.0%Unchanged
WPG Advisers, LLC18$5840.00%+18New
Rossby Financial, LCC14$4540.00%+14New
SRS Capital Advisors, Inc.11$3570.00%+11New
Quarry LP10$3250.00%+10New
Caitong International Asset Management Co., Ltd5$1620.00%+5New
EverSource Wealth Advisors, LLC2$650.00%+1+100.0%Added
Allworth Financial LP1$330.00%00.0%Unchanged
Opaleye Management Inc.0$00.00%−14,506−100.0%Sold out
Soleus Capital Management, L.P.0$00.00%−10,000−100.0%Sold out
STRS Ohio0$00.00%−5,100−100.0%Sold out
Janus Henderson Group PLC––––Not filed
CWM, LLC––––Not filed